Pharmacokinetic study of conventional sorafenib chemoembolization in a rabbit VX2 liver tumor model

PURPOSE: Use of oral sorafenib, an antiangiogenic chemotherapeutic agent for hepatocellular carcinoma (HCC), is limited by an unfavorable side effect profile. Transarterial chemoembolization (TACE) employs targeted intravascular drug administration, and has potential as a novel sorafenib delivery me...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Diagn Interv Radiol
Autori principali: Parvinian, Ahmad, Casadaban, Leigh C., Hauck, Zane Z., van Breemen, Richard B., Gaba, Ron C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Turkish Society of Radiology 2015
Soggetti:
Interventional Radiology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4463267/
https://ncbi.nlm.nih.gov/pubmed/25835078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/dir.2014.14394
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi